NAPROXEN
- Product NDC
- 69543-425
- 11-digit product format
- 695430425
- Labeler code
- 69543
- Product ID
- 69543-425_2c77658c-b5b6-4d22-a218-1334a0d13c02
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- NAPROXEN
- Dosage form
- TABLET, DELAYED RELEASE
- Route
- ORAL
- Labeler
- Virtus Pharmaceuticals, LLC
- Application
- ANDA091432
- Marketing category
- ANDA
- Marketing start
- 2019-11-15
- Marketing end
- 0000-00-00
- Substance
- NAPROXEN
- Active strength
- 375 mg/1
- Pharmacologic classes
- Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]
- NDC exclude flag
- No
- Listing certified through
- 2023-12-31
- Current FDA listing
- Historical FDA.report record
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 69543-425-10 | 69543042510 | 100 TABLET, DELAYED RELEASE in 1 BOTTLE (69543-425-10) | 2019-11-15 | 0000-00-00 | No | No | Current |